Compare drug alternatives

Qulipta® Alternatives

Qulipta®

(Atogepant)
Qulipta
Prescription Only
Qulipta is a prescription medication that is used as a preventative treatment for episodic migraines. It is a tablet that is taken once daily. The most common side effects are fatigue, nausea, and constipation. Qulipta is FDA approved for the following indications: Migraine prevention.

Emgality®

(Galcanezumab)
Emgality
Prescription Only
Emgality is a medication that can be self-administered once a month by injecting it subcutaneously under the skin. It is used for migraine prevention in adults and can also be used to treat cluster headaches during a cluster headache period. The most frequently reported side effect is injection site reactions. Additionally, there are no known drug interactions with Emgality. Emgality is FDA approved for the following indications: Migraine and Cluster Headaches.

Dosage & Administration

Administration
Oral
Subcutaneous
Dosing
10 mg, 30 mg, or 60 mg once daily. Severe Renal Impairment or End-Stage Renal Disease: 10 mg once daily.
Migraine: 240 mg loading dose (120 mg x 2) followed by 120 mg monthly.
Latin Shorthand
10mg qd, 30mg qd or 60mg qd Renal Impairment: 10mg qd
240 mg LD (120 mg x 2) then 120 mg/mo.

Financial Assistance

Copay
$0
$0
Annual Cap
$6,000
$4,900
Assistance Expiration
12 30-day prescription fills
12 months
Generics
No lower-cost generic available
No lower-cost generic available

Popular alternatives

Relevant Resources

Emgality
Qulipta